Trademark Overview
On Thursday, September 19, 2024, a trademark application was filed for STAGEOSIS with the United States Patent and Trademark Office. The USPTO has given the STAGEOSIS trademark a serial number of 79408532. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, May 29, 2025. This trademark is owned by GENFIT. The STAGEOSIS trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Downloadable and recorded software for use in the management of cancer, metabolic diseases and liver diseases, namely, software for creating customized care plans for patients, for managing patient data, for providing clinical decision support information and analytics, for managing patient medications, and for providing reporting and analytics relating to patient care, and for use in research and development of new pharmaceutical products for others, namely, software for managing, analyzing and reporting on clinical trial data; downloadable software applications for use in diagnosing medical conditions; scientific apparatus and instruments for recording, processing, reproduction and transmission of data, namely electronic data loggers and recorders; data processing equipment
Pharmaceutical preparations for the diagnosis, prevention and treatment of metabolic, hepatic and oncological diseases and disorders; diagnostic preparations and diagnostic biomarker reagents for medical use; medical diagnostic testing materials for medical use namely, diagnostic reagents and assays for testing of bodily fluids; blood and blood-derived samples for medical use, namely, blood substitutes for human use, blood plasma, serum and other blood-derived biological samples
Diagnostic preparations for industrial and scientific use; chemical reagents for industrial use; chemical reagents for scientific use
Medical analysis for the diagnosis, prevention and treatment of metabolic, hepatic and oncological diseases and disorders; medical analysis of blood samples; assistance services in the fields of medicine and health care; medical information; provision of medical information
Medical apparatus, instruments and equipment namely, DNA, RNA and protein analysis apparatus, DNA, RNA and protein quantifiers, medical devices for measuring DNA, RNA, biochemical and physical parameters, namely, concentration of biomarkers and blood analyzers for evaluation of metabolic, hepatic and oncological diseases and disorders; instruments and tools for medical diagnosis, namely diagnostic medical devices for diagnosis of metabolic, hepatic and oncological diseases and disorders, blood analysis apparatus, DNA and RNA analysis apparatus, gene analyzers, medical devices for measuring biochemical and physical parameters, namely, concentration of biomarkers relating to the evaluation of metabolic, hepatic and oncological diseases and disorders, and blood analyzers for evaluation of metabolic, hepatic and oncological diseases and disorders
Scientific and technological services, namely research in the medical, biomedical, and chemical fields, for the diagnosis, prevention and treatment of metabolic, hepatic and oncological diseases and disorders; biological research; clinical research and medical research in the field of diagnosis, prevention and treatment of metabolic, hepatic and oncological diseases and disorders; industrial analysis and industrial research services in the field of pharmacy; design and development of computer hardware and software; programming for computers
